Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors

Radiotherapy is widely used to treat cancer because it has the advantage of physically and functionally conserving the affected organ. To improve radiotherapy and investigate the molecular mechanisms of cellular radioresistance, we established a clinically relevant radioresistant (CRR) cell line, SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Yoshikazu, Mori, Miyuki, Kitahara, Shuji, Fukumoto, Motoi, Ezaki, Taichi, Mori, Shiro, Echigo, Seishi, Ohkubo, Yasuhito, Fukumoto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987081/
https://www.ncbi.nlm.nih.gov/pubmed/24464839
http://dx.doi.org/10.1002/cam4.185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987081/
https://www.ncbi.nlm.nih.gov/pubmed/24464839
http://dx.doi.org/10.1002/cam4.185

Ejemplares similares